Stenotrophomonas maltophilia: Results of Antimicrobial Susceptibility Testing and In Vitro Activity of the Combination of Ceftazidime and Moxifloxacin
KLIMIK JOURNAL, cilt.32, sa.1, ss.29-34, 2019 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 1
- Basım Tarihi: 2019
- Doi Numarası: 10.5152/kd.2019.08
- Dergi Adı: KLIMIK JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
- Sayfa Sayıları: ss.29-34
- İstanbul Üniversitesi Adresli: Evet
Özet
Objective: Recommended combination for the treatment of serious Stenotrophomonas maltophilia infections is ticarcillin-clavulanate and co-trimoxazole (SXT). However, first agent is not available in our country, and the second component may be a matter of antimicrobial resistance or intolerance. Therefore, we aimed to evaluate antimicrobial susceptibility testing results of S. maltophilia and in vitro activity of ceftazidime and moxifloxacin as a potential therapeutic alternative.